Time to stop routine prescription of low-molecular-weight heparin to women with recurrent pregnancy loss and inherited thrombophilia
- PMID: 37393104
- DOI: 10.1016/S0140-6736(23)01190-X
Time to stop routine prescription of low-molecular-weight heparin to women with recurrent pregnancy loss and inherited thrombophilia
Conflict of interest statement
We declare no competing interests.
Comment on
-
Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial.Lancet. 2023 Jul 1;402(10395):54-61. doi: 10.1016/S0140-6736(23)00693-1. Epub 2023 Jun 1. Lancet. 2023. PMID: 37271152 Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
